The company
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.

Celgene have 8.000 employees globally and have operations in 70 countries with manufacturing facilities in the US and EU. The key research facilities are located in New Jersey, California, Massachusetts and Spain.

Committed to Improving the Lives of Patients Worldwide
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

For further information about Celgene, please visit and

The Nordic Organisation
The Celgene Nordic team consist of approximately 100 employees with Nordic headquarters in Sweden (Kista outside Stockholm). There are also local Celgene offices in each Nordic country (localized in each capital). The Nordic organisation consist of a broad based mixture of functions and specialists such as Medical, Sales, Marketing, Market Access, Corporate Affairs, QA, Clinical trials, Safety, Compliance, General management, Finance, HR and others. Some resources are shared within the Nordics and others are primarily local resources.

Celgene reinvest into local research in the Nordic. There are currently 45 ongoing Investor Initiated Trials (IIT) in the Nordic with nearly 2.000 patients enrolled in more than 100 sites. The Celgene Clinical Development Trials programme includes 34 Clinical trials with currently 308 patients enrolled in 149 sites. We have currently 21 Clinical Development trials in different phases that are in start-up, ongoing or in follow up phase. Since 2007 we have had 49 trials in the Nordic with 364 patients enrolled. Today we have 80 sites participating in our trails.

The Medical department Nordic
has about 30 employees with primary focus on Medical affairs, Drug safety, Clinical research, Clinical trials, Medical information and Real World data. This in selected, prioritized therapeutic areas; Oncology, Hematology and Inflammation & Immunology (I&I).
All the diversity and the overall specialist competencies in the organisation creates a solid environment for a fruitful collaboration, both in the Nordic as well as locally.

Celgene Finland has a good position and a positive development. The Finnish team consists of about 10 people specialized in Medical affairs, Market Access, Corporate affairs and Sales. The Finnish office is situated in Vantaa outside Helsinki. The Finnish team is highly skilled and experienced with a well established cross functional collaboration.


Regional Medical Liaison I and I Finland, Celgene - TILLSATT

Key medical position to top priority therapeutic area

The position

Position: Regional Medical Liaison (RML) Inflammation and Immunology (I&I) Finland

Supervisor: Senior Manager Medical Affairs Rheumatology & Dermatology, Nordics

Department: Medical department

Location: Finland, preferably with daily access to the Celgene Finland office in Vantaa outside Helsinki. Frequent travelling to the Celgene Nordic headquarters in Stockholm (Kista) is included in the position.

The Regional Medical Liaison Finland (RML) is the local scientific expert who drives and executes medical and scientific communication and activities, including Investigator Initiated trials (IITs) in collaboration with external stakeholders and in line with the Celgene business strategy for the Rheumatology and Dermatology area. In addition, the RML develops and maintain relationships with key thought leaders (KTLs) and build an advocacy base among external specialists within the Rheumatology and Dermatology therapeutic areas.

Otezla® (apremilast)

Otezla is a novel pharmaceutical (introduced in the market 2015), belonging to a new class for the treatment indications Plaque Psoriasis and Psoriatic Arthritis. Otezla is reimbursed in Finland and Sweden for patients that are meeting the indication criteria. For more information about OTEZLA, please visit or

Opportunities with the role

· To represent Celgene, a leading global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients
· Work in an innovative, expansive, dynamic and values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses
· Having the opportunity to work with Otezla a novel state of the art treatment with high potential for Plaque Psoriasis and Psoriatic Arthritis
· Having the possibility to implement new ideas and projects with influence of company development
· Be part of a Nordic/Finnish team, with deep knowledge, highly motivated, and with a good cooperation and positive atmosphere
· Celgene has an attractive company culture with excellent opportunities for professional and personal development.

Experience, qualifications and competencies

Required experience, skills and qualifications

· Academic, scientific or medical degree, Pharm D, Msc and/or PhD in life sciences, or equivalent
- Experience from Medical Affairs or a similar position in the pharmaceutical industry is desirable
· Experience in dermatology, rheumatology, immunology, or other therapeutic area is an advantage

· Excellent verbal and written communication skills in English and Finnish. Knowledge in Swedish is an advantage.
· Advanced computer skills (MS office).
· Clean, valid drivers license
· Frequent travelling to customers in Finland, medical Congresses, internal meetings in the Nordic and Europe.

Critical Competencies for success

Scientific communication ability
Ability to quickly absorb scientific and medical data and adjust communication level depending on stakeholder’s level of expertise

Strong in collaboration- and people relation building
A top-class team player. Works effectively in a team-based organization, collaborates cross-functionally and builds alignment around goals and objectives. Readily builds consensus and achieves agreement on key initiatives and priorities. A strong ability to create and maintain relationships with KOLs.

Ability to work independently. Self-motivated and organized. Taking initiatives for new projects, solving problems, take decisions and create solutions to customer challenges.

Results orientation and customer focus
A result oriented individual, with a participative, strong personal work ethic, intense focus on results and a bias toward action. Focuses on customer needs and satisfaction, Sets high standards for quality and quantity. Establishes clear expectations, objectives and priorities. Diligently monitors progress and proactively addresses variances. Highly decisive and action-oriented.

For inquires and more information about the Regional Medical Liaison I&I position, please contact Magnus Klingberg, Senior Recruitment Consultant at PeakSearch.

Please apply for the position at
Contact details
mobile: +46 (0)70-678 09 92 office telephone:+46 (0)8-545 00 100